Braster S.A.

Equities

BRA

PLBRSTR00014

Biotechnology & Medical Research

Market Closed - Warsaw S.E. Other stock markets 11:55:54 2024-05-16 am EDT			5-day change	1st Jan Change
0.58 ^PLN	0.00%		0.00%	0.00%

2023	Braster S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI
2023	Braster S.A. Reports Earnings Results for the Half Year Ended June 30, 2023	CI

Braster S.A. announced that it expects to receive PLN 0.3 million in funding

April 19, 2017

Braster S.A. (WSE:BRA) announced a private placement of 3,000,000 series I common shares at an issue price of PLN 0.10 per share for gross proceeds of PLN 300,000 on April 20, 2017. The transaction has been approved by the shareholders of the company.

Latest news about Braster S.A.

Braster S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 29	CI
Braster S.A. Reports Earnings Results for the Half Year Ended June 30, 2023	23-10-03	CI
Braster S.A. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-24	CI
Braster S.A. Reports Earnings Results for the Full Year Ended December 31, 2022	23-05-02	CI
Braster S.A. Reports Earnings Results for the Full Year Ended December 31, 2022	23-05-02	CI
Braster S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-21	CI
Braster S.A. Reports Earnings Results for the Half Year Ended June 30, 2022	22-09-27	CI
Braster S.A. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-24	CI
Braster S.A. Reports Earnings Results for the Full Year Ended December 31, 2021	22-05-02	CI
Braster S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	21-11-29	CI
Braster S.A. Reports Earnings Results for the Half Year Ended June 30, 2021	21-09-30	CI
An unknown buyer acquired 21.38% stake in Braster S.A. from Carom Sp. z o.o.	21-09-22	CI
Braster S.A. Reports Earnings Results for the Full Year Ended December 31, 2020	21-04-30	CI
Braster Seeks To Raise Capital	18-07-06	CI
Braster S.A. announced that it has received PLN 0.3 million in funding	17-08-10	CI
Braster S.A. announced that it expects to receive PLN 0.3 million in funding	17-04-19	CI
Braster Negotiates Acquisitions	17-03-08	CI
Braster S.A. announced that it has received funding from Towarzystwo Funduszy Inwestycyjnych PZU SA	16-07-06	CI
Dom Maklerski Banku Ochrony Srodowiska S.A. sold 5.76% stake in Braster S.A..	16-06-30	CI
Medi-Koncept Sp. z o.o. sold 3.15% stake in Braster Spólka Akcyjna.	15-02-16	CI
Tadeusz Wesolowski acquired additional 4.3% stake in Braster Spólka Akcyjna.	15-02-16	CI

Chart Braster S.A.

Duration

Period

More charts

Company Profile

Braster SA w restrukturyzacji, formerly Braster SA, is a Poland-based company principally engaged in the bio diagnostics and testing. The Company provides research and development on breast cancer. It applies liquid crystals and liquid crystal emulsion formula that is used to produce liquid crystal matrix based on LCD technology, continuous film CLCF (Continuous Liquid Crystal Film) in the diagnosis of breast cancer. Its main product is Braster Tester, which is a device that uses thermographic liquid crystal matrices for diagnosing breast cancer; the device is made up of three film matrices covered with a liquid crystal mixture that allows thermal imaging. The Company cooperates with the Jagiellonian University, with the participation of the clinical trial conducted by Thermacrac, among others.

Sector

Biotechnology & Medical Research

More about the company

Income Statement Evolution

More financial data

Sector Bio Diagnostics & Testing

	1st Jan change	Capi.
BRASTER S.A.	0.00%	4.35M
EXACT SCIENCES CORPORATION	-29.78%	9.84B
GUARDANT HEALTH, INC.	-2.96%	3.15B
IOVANCE BIOTHERAPEUTICS, INC.	+28.23%	2.99B
BGI GENOMICS CO., LTD.	-14.73%	2.15B
VERACYTE, INC.	-15.05%	1.8B
MARAVAI LIFESCIENCES HOLDINGS, INC.	+69.62%	1.49B
CAREDX, INC	+23.08%	770M
SEEGENE, INC.	-2.84%	762M
ADAPTIVE BIOTECHNOLOGIES CORPORATION	-24.08%	575M

Bio Diagnostics & Testing